Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

365
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
365
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

394
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
394
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

673
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
673
Infection01:20

Infection

10.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
10.9K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

577
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
577
Prevalence and Incidence01:08

Prevalence and Incidence

1.3K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology, Genomic Diversity, and Evolutionary Dynamics of Human Metapneumovirus Over 7 Years of Integrated Community- and Hospital-Based Sentinel Surveillance in Senegal, 2018-2024.

Influenza and other respiratory viruses·2026
Same author

Mining corridors as emergence interfaces: an evidence-informed one health operational framework for prevention of infectious disease outbreaks in Kédougou, Senegal.

Frontiers in public health·2026
Same author

Emergence of an antigenically drifted and reassorted influenza B virus at the end of the 2024-25 influenza season.

mBio·2026
Same author

Genomic Surveillance of SARS-CoV-2 in Senegal (2020-2024): Variant Turnover, Omicron Introductions, and Interregional Spread.

Influenza and other respiratory viruses·2026
Same author

Evaluating myxovirus resistance protein A-based rapid testing combined with pathogen sequencing for arboviral and incidental viral infection surveillance in Senegal.

Microbiology spectrum·2026
Same author

[Highlights from the 2<sup>nd</sup> Congress of the Senegalese Society of Infectious and Tropical Pathology (SOSEPIT), Dakar, April 28-30, 2025].

Medecine tropicale et sante internationale·2026

Related Experiment Video

Updated: Dec 5, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

COVID-19 Outbreak, Senegal, 2020.

Ndongo Dia, Ndeye Aïssatou Lakh, Moussa Moise Diagne

    Emerging Infectious Diseases
    |October 15, 2020
    PubMed
    Summary
    This summary is machine-generated.

    The first cases of coronavirus disease (COVID-19) in Senegal were confirmed in March 2020. These initial cases were linked to international travel from Europe, indicating a later start to the pandemic in Africa compared to other continents.

    Keywords:
    COVID-19SARS-CoV-2Senegalcoronavirus diseaserespiratory infectionssevere acute respiratory syndrome coronavirus 2viruseszoonoses

    More Related Videos

    Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
    09:26

    Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

    Published on: June 30, 2023

    1.4K
    Remote Laboratory Management: Respiratory Virus Diagnostics
    14:56

    Remote Laboratory Management: Respiratory Virus Diagnostics

    Published on: April 6, 2019

    33.4K

    Related Experiment Videos

    Last Updated: Dec 5, 2025

    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
    03:53

    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

    Published on: November 10, 2023

    1.6K
    Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples
    09:26

    Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

    Published on: June 30, 2023

    1.4K
    Remote Laboratory Management: Respiratory Virus Diagnostics
    14:56

    Remote Laboratory Management: Respiratory Virus Diagnostics

    Published on: April 6, 2019

    33.4K

    Area of Science:

    • Epidemiology
    • Infectious Diseases
    • Public Health

    Background:

    • The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacted different continents at varying times.
    • Understanding the initial transmission dynamics of SARS-CoV-2 in specific regions is crucial for public health responses.

    Purpose of the Study:

    • To document the early epidemiological characteristics of coronavirus disease (COVID-19) in Senegal.
    • To identify the origins of the initial SARS-CoV-2 cases in Senegal.

    Main Methods:

    • Retrospective case identification based on confirmed diagnoses.
    • Analysis of epidemiological data including case dates and travel history.

    Main Results:

    • Senegal reported its first confirmed case of COVID-19 on March 2, 2020.
    • By March 4, 2020, a total of 4 cases were confirmed.
    • All initial cases were associated with recent travel history to Europe.

    Conclusions:

    • The introduction of SARS-CoV-2 into Senegal occurred in early March 2020.
    • International travel, particularly from Europe, was the primary driver of the initial COVID-19 cases in Senegal.
    • The onset of the pandemic in Senegal was later than in Asia and Europe.